Detalhe da pesquisa
1.
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.
Haematologica
; 106(6): 1559-1568, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32467145
2.
Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemia.
Hematol Oncol
; 39(5): 680-686, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34402088
3.
Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
Haematologica
; 104(2): 312-318, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30190342
4.
Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications.
Br J Haematol
; 181(5): 642-652, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29675955
5.
Clinical significance of recurrent copy number aberrations in B-lineage acute lymphoblastic leukaemia without recurrent fusion genes across age cohorts.
Br J Haematol
; 178(4): 583-587, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28439887
6.
IL7R overexpression in adult acute lymphoblastic leukemia is associated to JAK/STAT pathway mutations and identifies patients who could benefit from targeted therapies.
Leuk Lymphoma
; 60(3): 829-832, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30188230